Related Experiment Videos
Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis
M C Booth1, R V Atkuri, S K Nanda
1Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
Investigative Ophthalmology & Visual Science
|August 1, 1995
Summary
Staphylococcus aureus toxins worsen endophthalmitis by speeding retinal damage. Targeting these toxins early may preserve vision in bacterial eye infections.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Staphylococcus aureus is a common cause of bacterial endophthalmitis.
- The global regulator locus agr controls the expression of numerous toxins and exoproteins in S. aureus.
- The role of S. aureus toxins in the pathogenesis of endophthalmitis requires further elucidation.
Purpose of the Study:
- To investigate the contribution of S. aureus toxins to the severity of experimental endophthalmitis.
- To compare the pathogenicity of wild-type S. aureus with an agr-deficient strain.
Main Methods:
- Experimental endophthalmitis was induced in rabbit eyes using wild-type S. aureus ISP479 and an isogenic agr-deficient strain (ISP546).
- Infections were assessed using electroretinography (ERG), slit lamp biomicroscopy, and histology.
- Two bacterial concentrations (approx. 10 and 1000 organisms) were used for inoculation.
Main Results:
- The agr-deficient strain showed a slower loss of b-wave response on ERG compared to the wild-type strain.
- Lower inoculum (10 organisms) of the agr-deficient strain resulted in less severe clinical signs at 24 and 48 hours.
- Histology at 36 hours revealed focal retinal destruction with wild-type S. aureus but normal retinas with the agr-deficient strain.
- At 100% b-wave loss, histological retinal changes were indistinguishable between groups.
Conclusions:
- Toxin production by S. aureus significantly contributes to the severity of endophthalmitis.
- S. aureus toxins accelerate the onset and progression of retinal damage.
- Early administration of toxin-targeting therapies may be crucial for preserving retinal function in S. aureus endophthalmitis.